Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4

about

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4

Item

http://www.wikidata.org/entity/Q41381630

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4

@en

type

Item

label

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4

@en

prefLabel

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4

@en

P1476

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4

@en

P2093

Jia He

http://www.w3.org/2001/XMLSchema#string

Jian Feng

http://www.w3.org/2001/XMLSchema#string

Lichuang Men

http://www.w3.org/2001/XMLSchema#string

Shukui Qin

http://www.w3.org/2001/XMLSchema#string

Tianyi Zhang

http://www.w3.org/2001/XMLSchema#string

Wei Guo

http://www.w3.org/2001/XMLSchema#string

Xinji Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Sorafenib in advanced hepatocellular carcinoma

Hepatocellular carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.

International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study

Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer.

Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.

P304

1225-1232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2017.18.5.1225

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28610406

http://www.w3.org/2001/XMLSchema#string

P932

5555527

http://www.w3.org/2001/XMLSchema#string